Ms. Iris Bincovich reports

INNOCAN PHARMA ANNOUNCES PROMISING RESULTS FROM HAIR CARE CREAM EFFICACY TEST

Innocan Pharma Corp. has released the successful results of a controlled efficacy test (the trial) regarding its hair care cream.

• Innocan hair care cream efficacy trial observes enhanced hair growth in male and female participants in a 14-day period;
• 91 per cent of participants reported stronger hair and 100 per cent of participants reported reduced hair loss; the trial revealed significant hair growth improvements;
• These promising results further expand Innocan's rapidly growing portfolio of indication offerings, reinforcing the company's commitment to diversifying and enhancing its range of impactful wellness solutions.

The trial's findings underscore the effectiveness of Innocan's product, which is enriched with cannabinoids, peptides and other natural ingredients. The trial's findings demonstrate that the product enhances hair growth, resulting in increased hair density and thickness.

"We are profoundly encouraged by the outcomes of this trial and the evident benefits our hair care cream brought to the participants," said Iris Bincovich, chief executive officer of Innocan. "Our dedication remains unwavering: to innovate and deliver products that genuinely make a difference in people's lives, and this achievement underscores that commitment."

The 120-day trial engaged a diverse group of male and female volunteers experiencing non-seasonal hair loss. The trial's primary benchmark -- a statistically significant increase in hair growth -- was observed as early as 14 days postapplication, with hair-length elongation evident throughout the trial and showing a 22.5-per-cent increase in hair length.

Furthermore, 91 per cent of the volunteers reported that their hair was stronger, 100 per cent were satisfied from the attenuation in their hair loss, 87 per cent stated that their hair is denser and thicker as if they have more hair, and 100 per cent of the volunteers will recommend the use of the product to others. Area measured for hair length before and after 14 days of using the product.

Innocan's unique blend of cannabinoids and other natural ingredients presents a wholesome solution for those battling hair loss, aiming to not only prevent it but also promote the regrowth of fuller, thicker hair.

About Innocan Pharma Corp.

Innocan is a pharmaceutical tech company that operates under two main segments: pharmaceuticals and consumer wellness. In the pharmaceuticals segment, Innocan focuses on developing innovative drug delivery platform technologies comprises with cannabinoids science, to treat various conditions to improve patients' quality of life. This segment involves two drug delivery technologies: (i) LPT CBD- loaded liposome platform facilitating exact dosing and the prolonged and controlled release of CBD into the blood stream. The LPT delivery platform research is in the preclinical trial phase for two indications: epilepsy and pain management. (ii) CLX CBD-loaded exosomes platform that may hold the potential to provide a highly synergistic effect of regenerating and anti-inflammatory properties targeting the central nervous system (CNS). In the consumer wellness segment, Innocan develops and markets a wide portfolio of innovative and high-performance self-care products to promote a healthier lifestyle. Under this segment Innocan has established a joint venture by the name of BI Sky Global Ltd. that focuses developing on advanced targeted on-line sales.

We seek Safe Harbor.